30.08.2010 - Europe's drug regulator is reviewing the safety of Glaxosmithkline's Pandemrix swine flu vaccine, which has been given to more than 30 million people in Europe, to examine possible...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)